Literature DB >> 15928873

Evaluation of chitosan/beta-tricalcium phosphate microspheres as a constituent to PMMA cement.

Li-Chun Lin1, Shwu-Jen Chang, Shyh Ming Kuo, Shu Fen Chen, Chia Hung Kuo.   

Abstract

Two methods, a traditional emulsion technique and a high voltage electrostatically modified encapsulation system, were used to fabricate degradable chitosan/beta -tricalcium phosphate (beta-TCP) microspheres. The two distinct kinds of microspheres both exhibited good sphericity and the beta-TCP was trapped well inside the chitosan gel. The microspheres prepared by high voltage electrostatic system exhibited a rougher outer surface and narrower size distribution. These microspheres were then used as an added constituent to commercially available PMMA bone cement. Four modified cement composites that were prepared with different composition ratios of the two kinds of chitosan/beta-TCP microspheres that were made from emulsion technique (C1P1 and C2P1) and from a process by a high voltage electrostatic system (EC1P1 and EC2P1) were compared with the PMMA cement (Pure P). The characteristics of these materials indicate that with the addition of chitosan/beta-TCP microspheres as a constituent into the PMMA cement significantly decreases the curing peak temperature. Furthermore, the setting time increases from 3.5 min to 9 min, as compared to the PMMA cement. These changes could be beneficial for the handling of the bone cement paste and causing less damage to the surrounding tissues. Understandably, the presence of chitosan/beta-TCP microspheres in the prepared composites reduced the ultimate compressive strength and bending strength. From the degradation test and SEM observations, the modified chitosan/beta -TCP/PMMA composites could be degraded gradually and create rougher surfaces that would be beneficial to cell adherence and growth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15928873     DOI: 10.1007/s10856-005-0533-0

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  8 in total

1.  Blood protein adsorption onto chitosan.

Authors:  Johan Benesch; Pentti Tengvall
Journal:  Biomaterials       Date:  2002-06       Impact factor: 12.479

2.  Ceramic and PMMA particles differentially affect osteoblast phenotype.

Authors:  Christoph H Lohmann; David D Dean; Georg Köster; David Casasola; Gottfried H Buchhorn; Ulrich Fink; Zvi Schwartz; Barbara D Boyan
Journal:  Biomaterials       Date:  2002-04       Impact factor: 12.479

3.  New aspects of the effect of size and size distribution on the setting parameters and mechanical properties of acrylic bone cements.

Authors:  B Pascual; B Vázquez; M Gurruchaga; I Goñi; M P Ginebra; F J Gil; J A Planell; B Levenfeld; J San Román
Journal:  Biomaterials       Date:  1996-03       Impact factor: 12.479

4.  Enhanced osteoblast response to a polymethylmethacrylate-hydroxyapatite composite.

Authors:  Amr M Moursi; Alissa V Winnard; Phillip L Winnard; John J Lannutti; Robert R Seghi
Journal:  Biomaterials       Date:  2002-01       Impact factor: 12.479

5.  Development of bioactive bone cement and its clinical applications.

Authors:  T Yamamuro; T Nakamura; H Iida; K Kawanabe; Y Matsuda; K Ido; J Tamura; Y Senaha
Journal:  Biomaterials       Date:  1998-08       Impact factor: 12.479

6.  The characteristics of a hydroxyapatite-chitosan-PMMA bone cement.

Authors:  Seok Bong Kim; Young Jick Kim; Taek Lim Yoon; Su A Park; In Hee Cho; Eun Jung Kim; In Ae Kim; Jung-Woog Shin
Journal:  Biomaterials       Date:  2004-11       Impact factor: 12.479

7.  Studies on gelatin-based sponges. Part III: a comparative study of cross-linked gelatin/alginate, gelatin/hyaluronate and chitosan/hyaluronate sponges and their application as a wound dressing in full-thickness skin defect of rat.

Authors:  Y S Choi; S B Lee; S R Hong; Y M Lee; K W Song; M H Park
Journal:  J Mater Sci Mater Med       Date:  2001-01       Impact factor: 3.896

8.  Surface studies on acrylic bone cement.

Authors:  A Bettencourt; A Calado; J Amaral; A Alfaia; F M Vale; J Monteiro; M F Montemor; M G S Ferreira; M Castro
Journal:  Int J Pharm       Date:  2004-06-18       Impact factor: 5.875

  8 in total
  4 in total

1.  The Application of Microencapsulation Techniques in the Treatment of Endodontic and Periodontal Diseases.

Authors:  Asteria Luzardo Alvarez; Francisco Otero Espinar; José Blanco Méndez
Journal:  Pharmaceutics       Date:  2011-08-26       Impact factor: 6.321

Review 2.  Controlling Antibiotic Release from Polymethylmethacrylate Bone Cement.

Authors:  Victoria Wall; Thi-Hiep Nguyen; Nghi Nguyen; Phong A Tran
Journal:  Biomedicines       Date:  2021-01-01

Review 3.  Role of Implantable Drug Delivery Devices with Dual Platform Capabilities in the Prevention and Treatment of Bacterial Osteomyelitis.

Authors:  Caroline Billings; David E Anderson
Journal:  Bioengineering (Basel)       Date:  2022-02-06

4.  Effects of Incorporating Carboxymethyl Chitosan into PMMA Bone Cement Containing Methotrexate.

Authors:  Bo-Ming Liu; Ming Li; Bao-Sheng Yin; Ji-Yang Zou; Wei-Guo Zhang; Shou-Yu Wang
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.